{
    "id": 3451,
    "name": "skin carcinoma",
    "source": "DOID",
    "definition": "A skin cancer that is located_in tissues of the skin and develops from epithelial cells. [url:http\\://www.cancer.gov/cancertopics/types/skin]",
    "currentPreferredTerm": null,
    "lastUpdateDateFromDO": "03/24/2020",
    "altIds": [
        
    ],
    "termId": "DOID:3451",
    "evidence": [
        {
            "id": 10787,
            "approvalStatus": "Preclinical - Cell line xenograft",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, CVX-241 inhibited tumor growth in a skin carcinoma cell line xenograft model (PMID: 21149738).",
            "molecularProfile": {
                "id": 17605,
                "profileName": "Unknown unknown"
            },
            "therapy": {
                "id": 5619,
                "therapyName": "CVX-241",
                "synonyms": null
            },
            "indication": {
                "id": 3451,
                "name": "skin carcinoma",
                "source": "DOID"
            },
            "responseType": "not applicable",
            "references": [
                {
                    "id": 8821,
                    "pubMedId": 21149738,
                    "title": "Chemical generation of bispecific antibodies.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/21149738"
                }
            ],
            "ampCapAscoEvidenceLevel": "NA",
            "ampCapAscoInferredTier": "NA"
        }
    ],
    "clinicalTrials": [
        
    ]
}